IMDX
Insight Molecular Diagnostics
IMDX
IMDX
30 hedge funds and large institutions have $15.5M invested in Insight Molecular Diagnostics in 2016 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 9 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
56% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 9
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Holders
30
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$7.75M | |
| 2 | +$45K | |
| 3 | +$14.6K | |
| 4 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
+$1.44K |
Top Sellers
| 1 | -$105K | |
| 2 | -$58.9K | |
| 3 | -$42K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$7.46K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$3.29K |